Granuloma annulare as a complication of mesotherapy: A case report

Dermatologic Surgery

Volumn 34, Issue 6, 2008, Pages 836-838

  Strahan, Jamison E ^a   Cohen, Joel L ^a,b   Chorny, Joe A ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b AboutSkin Dermatology   (United States)

^c Colorado Pathology Consultants PC ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE SALT; DEOXYCHOLIC ACID; EMULSIFYING AGENT; PHOSPHATIDYLCHOLINE; STEROID;

ADULT; ARTICLE; BODY FAT; CASE REPORT; CELLULITE; DIFFERENTIAL DIAGNOSIS; FEMALE; GRANULOMA ANNULARE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPOLYSIS; MESOTHERAPY; PRIORITY JOURNAL; SKIN DISEASE; SKIN SURGERY;

ABDOMEN; ADULT; COSMETIC TECHNIQUES; FEMALE; GRANULOMA ANNULARE; HUMANS; INJECTIONS, SUBCUTANEOUS; PHOSPHATIDYLCHOLINES;

EID: 44849103812     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2008.34156.x     Document Type: Article

References (17)

1. Rotunda Adam M, Kolodney Michael S. Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg 2006 32:465 80.
2. Galson SK. (Senate Hearing Statement) Federal and state role in pharmacy compounding and reconstitution: exploring the right mix to protect patients. Washington, DC:United States Food and Drug Administration 2003. Available from:. [Accessed Feb 24, 2008]
3. Centers for Disease Control and Prevention (CDC). Outbreak of mesotherapy-associated skin reactions - District of Columbia area, January-February 2005. Morb Mortal Wkly Rep 2005 54:1127 30.
4. Nagore E, Ramos P, Botella-Estrada R, et al. Cutaneous infection with Mycobacterium fortuitum after localized microinjections (mesotherapy) treated successfully with a triple drug regimen. Acta Derm Venereol 2001 81:291 3.
5. Bessis D, Guilhou JJ, Guillot B. Localized urticaria pigmentosa triggered by mesotherapy. Dermatology 2004 209:343 4.
6. Urbani CE. Urticarial reaction to ethylenediamine in aminophylline following mesotherapy. Contact Dermatitis 1994 31:198 9.
7. Lee DP, Chang SE. Subcutaneous nodules showing fat necrosis owing to mesotherapy. Dermatol Surg 2005 31:250 1.
8. Rosina P, Chieregato C, Miccolis D, D'Onghia FS. Psoriasis and side-effects of mesotherapy. Int J Dermatol 2001 40:581 3.
9. Colon-Soto M, Peredo RA, Vila LM. Systemic lupus erythematosus after mesotherapy with acetyl-l-carnitine. J Clin Rheumatol 2006 12:261 2.
10. Palmer M, Curran J, Bowler P. Clinical experience and safety using phosphatidylcholine injections for the localized reduction of subcutaneous fat: a multicentre, retrospective UK study. J Cosmet Dermatol 2006 5:218 26.
11. Rittes PG. The use of phosphatidylcholine for correction of lower lid bulging due to prominent fat pads. Dermatol Surg 2001 27:391 2.
12. Ablon G, Rotunda AM. Treatment of lower eyelid fat pads using phosphatidylcholine: clinical trial and review. Dermatol Surg 2004 30:422 7.
13. Hexsel D, Serra M, Mazzuco R, et al. Phosphatidylcholine in the treatment of localized fat. J Drugs Dermatol 2003 2:511 8.
14. Rittes PG. The use of phosphatidylcholine for correction of localized fat deposits. Aesthet Plast Surg 2003 27:315 8.
15. Duncan DI, Hasengschwandtner F. Lipodissolve for subcutaneous fat reduction and skin retraction. Aesthet Surg J 2005 25:530 43.
16. Rose PT, Morgan M. Histological changes associated with mesotherapy for fat dissolution. J Cosmet Laser Ther 2005 7:17 9.
17. Rapaport MJ. Granuloma annulare caused by injectable collagen. Arch Dermatol 1984 120:837 8.